Cargando…

A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients

BACKGROUND: We investigated whether a low fixed Tac starting dose regimen could lead to a better achievement of Tac target concentrations, as well as an effective immunosuppressive treatment, in Chinese kidney transplant recipients (KTRs). MATERIAL/METHODS: We collected whole-blood and serum samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jiang-Tao, Yan, Lin, Wang, Lan-Lan, Bai, Yang-Juan, Li, Ya-Mei, Zou, Yuan-Gao, Li, Yi, van Gelder, Teun, Shi, Yun-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248022/ https://www.ncbi.nlm.nih.gov/pubmed/29735966 http://dx.doi.org/10.12659/AOT.907666

Ejemplares similares

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients
por: Andrews, L. M., et al.
Publicado: (2019)

Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose
por: Andrews, Louise M., et al.
Publicado: (2017)

Lower versus higher starting tacrolimus dosing in kidney transplant recipients
por: Chua, Justin C. M., et al.
Publicado: (2022)

A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation
por: Andrews, Louise M., et al.
Publicado: (2017)

Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients
por: Yan, Lin, et al.
Publicado: (2019)

A Population Pharmacokinetic Model Does Not Predict the Optimal Starting Dose of Tacrolimus in Pediatric Renal Transplant Recipients in a Prospective Study: Lessons Learned and Model Improvement
por: Andrews, Louise M., et al.
Publicado: (2019)

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial
por: Francke, Marith I., et al.
Publicado: (2021)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients
por: Tang, Jie, et al.
Publicado: (2017)

Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients
por: Francke, Marith I., et al.
Publicado: (2020)

Corrigendum: Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients
por: Tang, Jie, et al.
Publicado: (2018)

A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients
por: Bunthof, Kim L. W., et al.
Publicado: (2021)

Epidermal Cysts in a Tacrolimus Treated Renal Transplant Recipient
por: Ahn, In Su, et al.
Publicado: (2011)

Massive pleural effusion in a renal transplant recipient on tacrolimus
por: Nayagam, L. S., et al.
Publicado: (2014)

Genotype-guided tacrolimus dosing in African American kidney transplant recipients
por: Sanghavi, K., et al.
Publicado: (2015)

The Clinical Impact of the C(0)/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
por: van Gelder, Teun, et al.
Publicado: (2020)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Genomewide association study identifies a novel variant associated with tacrolimus trough concentration in Chinese renal transplant recipients
por: Yang, Siyao, et al.
Publicado: (2022)

Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored
por: González, Fernando, et al.
Publicado: (2017)

Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients
por: Yu, Xiaobo, et al.
Publicado: (2011)

A new method to calculate intra‐patient variability in tacrolimus concentrations
por: van Gelder, Teun
Publicado: (2021)

The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy
por: Chen, Xu-Tao, et al.
Publicado: (2019)

Tacrolimus as a Rare Cause of Pericardial Effusion in a Renal Transplant Recipient
por: Prashar, Rohini, et al.
Publicado: (2017)

CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
por: Li, Yi, et al.
Publicado: (2015)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Retraction: Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients
Publicado: (2019)

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
por: Krzyżowska, Kinga, et al.
Publicado: (2018)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
por: Thölking, Gerold, et al.
Publicado: (2020)

Comparable Renal Function at 6 Months with Tacrolimus Combined with Fixed-Dose Sirolimus or MMF: Results of a Randomized Multicenter Trial in Renal Transplantation
por: Van Gurp, Eveline, et al.
Publicado: (2010)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
por: Dashti-Khavidaki, S., et al.
Publicado: (2016)

Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
por: Chegounchi, Marjan, et al.
Publicado: (2006)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
por: Chen, Lucy, et al.
Publicado: (2018)

Endoscopic Botulinum Toxin Injection for Tacrolimus-Induced Achalasia in a Renal Transplant Recipient
por: Campos, Marilia, et al.
Publicado: (2019)

Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study
por: de Weerd, Annelies E., et al.
Publicado: (2022)

Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients
por: Lai, Elaine F., et al.
Publicado: (2022)

Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study
por: Lenain, Rémi, et al.
Publicado: (2021)

Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
por: Nasiri-Toosi, Zahra, et al.
Publicado: (2014)

Gout Due to Tacrolimus in a Liver Transplant Recipient
por: Afridi, Summia Matin, et al.
Publicado: (2019)

A Physiologically Based Pharmacokinetic Approach to Recommend an Individual Dose of Tacrolimus in Adult Heart Transplant Recipients
por: Pei, Ling, et al.
Publicado: (2023)

Predicting model‐informed precision dosing: A test‐case in tacrolimus dose adaptation for kidney transplant recipients
por: Faelens, Ruben, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_heikttid3kd0l0ae12ui72m8pp